Chapters (66)
- Title Page
- Copyright Notice
- Dedication
- Epigraphs
- Contents
- Prologue
- Chapter 1
- Chapter 2
- Chapter 3
- Chapter 4
- Chapter 5
- Chapter 6
- Chapter 7
- Chapter 8
- Chapter 9
- Chapter 10
- Chapter 11
- Chapter 12
- Chapter 13
- Chapter 14
- Chapter 15
- Chapter 16
- Chapter 17
- Chapter 18
- Chapter 19
- Chapter 20
- Chapter 21
- Chapter 22
- Chapter 23
- Chapter 24
- Chapter 25
- Chapter 26
- Chapter 27
- Chapter 28
- Chapter 29
- Chapter 30
- Chapter 31
- Chapter 32
- Chapter 33
- Chapter 34
- Chapter 35
- Chapter 36
- Chapter 37
- Chapter 38
- Chapter 39
- Chapter 40
- Chapter 41
- Chapter 42
- Chapter 43
- Chapter 44
- Chapter 45
- Chapter 46
- Chapter 47
- Chapter 48
- Chapter 49
- Chapter 50
- Chapter 51
- Chapter 52
- Chapter 53
- Chapter 54
- Chapter 55
- Chapter 56
- The Boston Globe
- Also by Michael Palmer
- About the Author
- Copyright
Becca Seabury’s antecubital space—the inside of her elbow—looked like ground beef that had been left in the sun. Muscle fibers, tendons, ligaments, all basted in thick, greenish purulence, glinted beneath the portable saucer light overhead. Beebe heard his brilliant chief resident inhale sharply, and vowed to reprimand her for the audible reaction as soon as it was appropriate. In the next moment, he decided not to mention it.
“Becca, it’s Dr. Beebe. Can you hear me?”
There was little response except a fitful moan. Beebe, his jaw set, looked across the bed at the chief of infectious disease.
“Sid?” he asked
Sidney Fleishman shrugged and shook his head. “As you can see, she’s still toxic. No change in the bug, and no effect from every antibiotic in our arsenal. Her white count has dipped a bit, but there are no other signs that we’re winning. We’ve gotten permission to try one of the most promising experimental drugs that is being tested on strep and MRSA, but this Doomsday G—this bacteria—is like nothing we’ve seen. Strep, but not really strep, resistant to methicillin and vancomycin, and carbapenem.”
“Conclusion?”
“I think we have some time. Not much, but some—especially with the infection still limited to her elbow.”
Beebe inhaled deeply and exhaled slowly. Fleishman, as bright as anyone at White Memorial, was advocating a continued conservative approach with the addition of a new, experimental drug, which was showing effectiveness against methicillin-resistent staph aureus.
How much time do you think? Beebe was about to ask when Jennifer Lowe, Becca’s nurse, standing at the foot of the bed, cleared her throat by way of interruption. She had been massaging lotion onto Becca’s left foot and now had turned her attention to the right one.
“Dr. Beebe, I think you’d better have a look at this,” she said. “I didn’t see anything here an hour ago.”
She gently folded back the sheet and gestured to the foot. All five toes were reddened, and swelling extended two inches toward the ankle.
Beebe stepped to his right and inspected this new development—first with his eyes, then with his gloved hands.
“Sid?”
Fleishman studied the foot, then checked for swollen lymph nodes in their patient’s right groin—often a sign of expanding infection.
“Nothing yet,” he said, “but this is clearly new infection, probably seeded from her arm.”
Chandler Beebe ran his tongue across his lips and took one more breath.
“Jennifer, is the OR ready?” he asked.
“It is.”
“Call to tell them we’re bringing Rebecca Seabury down for removal of a septic right arm. I’ll speak to her family. Thank you for your efforts, everyone. My team, go ahead. I’ll meet you in the OR. Oh, and Jennifer, call pathology, please, and tell them we’ll be sending down a specimen.”